Unraveling hallmark suitability for staging pre- and post-implantation stem cell models

Cell Rep. 2024 May 28;43(5):114232. doi: 10.1016/j.celrep.2024.114232. Epub 2024 May 17.

Abstract

The advent of novel 2D and 3D models for human development, including trophoblast stem cells and blastoids, has expanded opportunities for investigating early developmental events, gradually illuminating the enigmatic realm of human development. While these innovations have ushered in new prospects, it has become essential to establish well-defined benchmarks for the cell sources of these models. We aimed to propose a comprehensive characterization of pluripotent and trophoblastic stem cell models by employing a combination of transcriptomic, proteomic, epigenetic, and metabolic approaches. Our findings reveal that extended pluripotent stem cells share many characteristics with primed pluripotent stem cells, with the exception of metabolic activity. Furthermore, our research demonstrates that DNA hypomethylation and high metabolic activity define trophoblast stem cells. These results underscore the necessity of considering multiple hallmarks of pluripotency rather than relying on a single criterion. Multiplying hallmarks alleviate stage-matching bias.

Keywords: CP: Developmental biology; CP: Stem cell research; cell fate; epiblast; hallmarks; peri-implantation development; pluripotency; trophectoderm; trophoblast.

MeSH terms

  • Cell Differentiation
  • DNA Methylation
  • Embryo Implantation
  • Epigenesis, Genetic
  • Humans
  • Models, Biological
  • Pluripotent Stem Cells / cytology
  • Pluripotent Stem Cells / metabolism
  • Proteomics / methods
  • Transcriptome / genetics
  • Trophoblasts* / cytology
  • Trophoblasts* / metabolism